Free Trial
NASDAQ:CELU

Celularity (CELU) Stock Price, News & Analysis

Celularity logo
$2.22 +0.03 (+1.37%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$2.18 -0.04 (-1.58%)
As of 09/19/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Celularity Stock (NASDAQ:CELU)

Advanced

Key Stats

Today's Range
$2.15
$2.30
50-Day Range
$2.11
$4.15
52-Week Range
$1.00
$5.22
Volume
383,526 shs
Average Volume
140,591 shs
Market Capitalization
$59.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Celularity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

CELU MarketRank™: 

Celularity scored higher than 30% of companies evaluated by MarketBeat, and ranked 790th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Celularity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    Celularity has a consensus price target of $6.00, representing about 170.3% upside from its current price of $2.22.

  • Amount of Analyst Coverage

    Celularity has only been the subject of 1 research reports in the past 90 days.

  • Read more about Celularity's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Celularity is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Celularity is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Celularity has a P/B Ratio of 6.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Celularity's valuation and earnings.
  • Percentage of Shares Shorted

    11.33% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Celularity has recently increased by 3.68%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Celularity does not currently pay a dividend.

  • Dividend Growth

    Celularity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.33% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Celularity has recently increased by 3.68%, indicating that investor sentiment is decreasing.
    • Insider Buying vs. Insider Selling

      In the past three months, Celularity insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      22.10% of the stock of Celularity is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 19.02% of the stock of Celularity is held by institutions.

    • Read more about Celularity's insider trading history.
    Receive CELU Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Celularity and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    CELU Stock News Headlines

    WBB Securities Upgrades Celularity (CELU)
    Celularity (NASDAQ:CELU) Upgraded to Buy at WBB Securities
    Prepare for the “Mar-a-Lago Accord” Money Shock
    Why Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.tc pixel
    Celularity Receives Nasdaq Notice Regarding Form 10-Q
    See More Headlines

    CELU Stock Analysis - Frequently Asked Questions

    Celularity's stock was trading at $2.08 at the start of the year. Since then, CELU shares have increased by 6.7% and is now trading at $2.22.

    Celularity, Inc. (NASDAQ:CELU) posted its earnings results on Friday, August, 29th. The company reported ($1.02) earnings per share (EPS) for the quarter. The company had revenue of $5.74 million for the quarter. Celularity had a negative net margin of 165.22% and a negative trailing twelve-month return on equity of 459.57%.

    Celularity's stock reverse split before market open on Thursday, February 29th 2024.The 1-10 reverse split was announced on Thursday, February 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

    Celularity's top institutional shareholders include Valmark Advisers Inc. (0.21%), Bank of America Corp DE (0.16%), XTX Topco Ltd (0.09%) and Simplex Trading LLC. Insiders that own company stock include Kok Thay Lim and Robert J Hariri.
    View institutional ownership trends
    .

    Shares of CELU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Celularity investors own include NVIDIA (NVDA), Meta Platforms (META), Lovesac (LOVE), MannKind (MNKD), PayPal (PYPL), Tesla (TSLA) and Advanced Micro Devices (AMD).

    Company Calendar

    Last Earnings
    8/29/2025
    Today
    9/19/2025
    Next Earnings (Estimated)
    11/05/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CELU
    CIK
    1752828
    Fax
    N/A
    Employees
    220
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $6.00
    Low Price Target
    $6.00
    Potential Upside/Downside
    +170.3%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($3.18)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$57.89 million
    Net Margins
    -165.22%
    Pretax Margin
    -165.21%
    Return on Equity
    -459.57%
    Return on Assets
    -57.71%

    Debt

    Debt-to-Equity Ratio
    4.07
    Current Ratio
    0.25
    Quick Ratio
    0.19

    Sales & Book Value

    Annual Sales
    $54.22 million
    Price / Sales
    1.09
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $0.37 per share
    Price / Book
    6.00

    Miscellaneous

    Outstanding Shares
    26,690,000
    Free Float
    20,792,000
    Market Cap
    $59.25 million
    Optionable
    Optionable
    Beta
    0.81

    Social Links

    5G Stocks: The Path Forward is Profitable Cover

    Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

    Get This Free Report

    This page (NASDAQ:CELU) was last updated on 9/20/2025 by MarketBeat.com Staff
    From Our Partners